Clin2
NCT07035769Worth exploringRecruiting

Debio 1453P safety study in healthy adults

Healthy Participants

This trial tests an experimental oral drug, Debio 1453P, for the first time in people. Healthy adults can take part to see if the drug is safe and how the body processes it.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
88 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You are between 18 and 55 years old.
  • Your body mass index (BMI) is between 18.5 and 30.
  • You are generally healthy with no major medical conditions.
  • You have not taken any medications (including over-the-counter drugs, supplements, or vaccines) for 2 weeks before the start of the study, except small amounts of acetaminophen (Tylenol).
  • You do not have a history of drug or alcohol abuse in the last 2 years.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07463196Recruiting· Phase 1
Safety study of ACI-19764 in healthy adults

This trial tests a new oral medication, ACI-19764, in healthy adults to see how safe it is and how the body processes it. It may help researchers understand how the drug affects the immune system, which could lead to future treatments for certain conditions.

Groningen
NCT07232121Recruiting· Phase 1
Safety study of DF5112 in healthy adults

This study tests a new drug called DF5112 in healthy adults to find the safest dose. It helps doctors learn how the drug works in the body before testing it in people with a condition.

Sydney, New South Wales
NCT07780383Not yet recruiting· Phase 1
Single-dose study for healthy adults and early Alzheimer's participants

This trial tests a new investigational drug, BMS-986446, given as a single dose to healthy volunteers and multiple doses to people with early Alzheimer's disease. It aims to understand how the drug moves in the body, its safety, and whether it triggers an immune response, which could help guide future treatment for Alzheimer's.

Anaheim, California
NCT07486115Recruiting· Phase 1
Testing safety of BI 3814916 in healthy volunteers

This trial tests how safe and tolerable different doses of the study drug BI 3814916 are in healthy adults. It helps find the right dose for future studies.

Edegem
NCT07662148Recruiting· Phase 1
Testing the safety of BIIB144 in healthy adults

This trial tests a single dose of an experimental drug (BIIB144) in healthy adults to see if it is safe and how the body handles it. You would receive either the drug or a placebo (inactive shot) and be closely monitored.

Las Vegas, Nevada
NCT07225517Recruiting· Phase 1
Safety study of BIIB145 in healthy adults

This study tests a new drug called BIIB145 in healthy volunteers to see if it's safe and how the body handles it. It helps researchers learn about the drug before testing it in people with specific conditions.

Austin, Texas

Hear when a new Healthy Participants trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.